8-K: Clarivate Reports Mixed Q1 2024 Results, Reaffirms Full-Year Outlook

Clarivate's first quarter results show a slight revenue decrease and a net loss, but the company reaffirms its 2024 outlook.

Summary

• Clarivate reported a 1.3% decrease in revenue to $621.2 million for the first quarter of 2024.
• Organic revenue declined by 1.7%, with subscription revenue increasing by 2.4% but offset by a decrease in transactional and other revenues of 11.4% and re-occurring revenues of 5.1%.
• The company experienced a net loss attributable to ordinary shares of $93.8 million, or $0.14 per diluted share.
• Adjusted net income decreased by 20.9% to $103.5 million, and adjusted diluted EPS decreased by 22.2% to $0.14.
• Adjusted EBITDA decreased by 6.5% to $236.3 million, with the adjusted EBITDA margin decreasing to 38.0%.
• Net cash provided by operating activities decreased by $51.3 million to $176.2 million, and free cash flow decreased by $56.4 million to $111.8 million.
• Clarivate reaffirmed its 2024 outlook, expecting revenue between $2.57 billion and $2.67 billion, organic revenue growth between 0% and 2%, adjusted EBITDA between $1.055 billion and $1.115 billion, and free cash flow between $420 million and $500 million.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the revenue decline, net loss, and decreases in key financial metrics. However, the reaffirmation of the full-year outlook and progress in certain segments provide some positive aspects.

Positives

• Subscription revenues saw a 2.4% organic increase, driven by price increases.
• The company made progress on product investments and operational initiatives.
• The Intellectual Property segment refined its go-to-market model and saw success with software solutions like IPFolio.
• Derwent renewal rates improved in the Intellectual Property segment.
• Clarivate secured deals with two top-10 global pharmaceutical clients in the Life Sciences & Healthcare segment.
• The company acquired MotionHall and Global QMS, Inc., which will enhance its portfolio and expertise in the LS&H segment.
• Clarivate reaffirmed its full-year 2024 outlook, indicating confidence in future performance.
• The company refinanced its term loan, extending the maturity to 2031 and repaid $47m of principal.

Negatives

• Total revenue decreased by 1.3% to $621.2 million.
• Organic revenue declined by 1.7%.
• Transactional and other revenues decreased by 11.4% organically.
• Re-occurring revenues decreased by 5.1% organically.
• The company reported a net loss of $93.8 million.
• Adjusted net income decreased by 20.9% to $103.5 million.
• Adjusted diluted EPS decreased by 22.2% to $0.14.
• Adjusted EBITDA decreased by 6.5% to $236.3 million.
• Net cash provided by operating activities decreased by $51.3 million.
• Free cash flow decreased by $56.4 million.

Risks

• The company faces risks related to market conditions, which could impact its ability to achieve its growth targets.
• There are risks associated with the integration of acquired companies.
• The company's performance is subject to fluctuations in foreign exchange rates.
• The company's forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially.
• The company's reliance on non-GAAP financial measures may not be comparable to other companies.

Future Outlook

Clarivate reaffirmed its 2024 full-year outlook, expecting improved growth across its three segments driven by product investments and modestly improving market conditions. They anticipate a sequential improvement in organic revenue growth in the second quarter compared to the first quarter. The full year outlook assumes no further acquisitions, divestitures, or unanticipated events.

Management Comments

• Jonathan Gear, Chief Executive Officer, stated that the company is making great progress on key objectives including product investments and operational initiatives to drive future organic revenue growth.
• Jonathan Collins, Executive Vice President and Chief Financial Officer, noted that first quarter results were in line with expectations and reaffirmed the 2024 full year outlook.

Industry Context

Clarivate operates in the information services industry, providing data and analytics to various sectors. The results reflect a mixed performance, with some segments showing growth while others face headwinds. The company's focus on AI and product development aligns with broader industry trends towards digital transformation and data-driven decision-making.

Comparison to Industry Standards

• Clarivate's performance is mixed when compared to industry peers. Companies like RELX and Thomson Reuters, which also provide information and analytics, have shown more stable revenue growth in recent periods.
• The decline in Clarivate's transactional revenue is a concern, as many information service companies are seeing growth in this area. This could indicate a need for Clarivate to re-evaluate its offerings in this segment.
• The company's subscription revenue growth is positive, but it is important to note that this is largely driven by price increases, which may not be sustainable in the long term.
• Clarivate's adjusted EBITDA margin of 38.0% is lower than some of its peers, suggesting that the company may need to improve its cost management.
• The company's free cash flow decline is also a concern, as it could limit its ability to invest in future growth.

Stakeholder Impact

• Shareholders may be concerned about the net loss and decline in key financial metrics.
• Employees may be impacted by the company's restructuring efforts.
• Customers may benefit from the company's product investments and new offerings.
• Creditors may be impacted by the company's debt repayment plans.

Next Steps

• Clarivate will host a conference call and webcast to review the results.
• The company plans to continue product investments and operational initiatives to drive future organic revenue growth.
• The company expects a sequential improvement in organic revenue growth in the second quarter compared to the first quarter.
• The company plans to continue to prioritize debt repayment.

Key Dates

Keywords

Clarivate, Financial Results, Q1 2024, Revenue, EBITDA, Organic Growth, Subscription Revenue, Free Cash Flow, Intellectual Property, Life Sciences, Healthcare, Acquisitions